87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Enzyme identified as new therapeutic target for 'cold' tumors

Enzyme identified as new therapeutic target for 'cold' tumors

by Rebecca Dzombak,University of MichiganCredit: Pixabay/CC0 Public DomainA study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunothera

Enzyme identified as new therapeutic target for 'cold' tumors

by Rebecca Dzombak,University of MichiganCredit: Pixabay/CC0 Public DomainA study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunothera
Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP

Advanced cancer models could help personalize lymphoma treatments

Advanced cancer models could help personalize lymphoma treatmentsby Nik Papageorgiou,Ecole Polytechnique Federale de LausanneLymphomoid spiral. Credit: Albert Santamaria-MartinezScientists at EP
DNA secreted by tumor cell extracellular vesicles prompts anti-metastatic immune response

DNA secreted by tumor cell extracellular vesicles prompts anti-metastatic immune response

byWeill Cornell Medical CollegeCredit: CC0 Public DomainSpecially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the live

DNA secreted by tumor cell extracellular vesicles prompts anti-metastatic immune response

byWeill Cornell Medical CollegeCredit: CC0 Public DomainSpecially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the live
New toolkit to support the collection of cancer-patient-reported outcome measures

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac

New toolkit to support the collection of cancer-patient-reported outcome measures

byUniversity of Strathclyde, GlasgowCredit: Pixabay/CC0 Public DomainA new Scotland-wide toolkit is supporting the collection of patient-reported outcome measures (PROMs) to understand the impac
Overcoming glioblastoma resistance to chemotherapy

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &

Overcoming glioblastoma resistance to chemotherapy

byInstitute for Basic ScienceThe "onion model" illustrates how the one-by-one inactivation of the DNA repair pathways brings about changes in TMZ-induced mutational signatures. Every &
Opioids interfere with cancer immunotherapy, but another type of drug could help

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of

Opioids interfere with cancer immunotherapy, but another type of drug could help

byUniversity of PittsburghCredit: Etatics Inc. from PexelsOpioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the effectiveness of
Molecular 'ZIP code' draws killer T cells to brain tumors

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s

Molecular 'ZIP code' draws killer T cells to brain tumors

by Levi Gadye,University of California, San FranciscoProgramming tissue-sensing T cells to deliver therapeutics to the brain. Credit:Science(2024). DOI: 10.1126/science.adl4237UCSF s
Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d

Auto hematopoietic cell transplant not beneficial for mantle cell lymphoma with undetectable residual disease

by Elana GotkineAutologous hematopoietic cell transplant (auto-HCT) is not beneficial for patients with mantle cell lymphoma (MCL) in first complete remission (CR) with undetectable minimal residual d